By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

MorphoSys AG 

Lena-Christ-Strasse 48

Martinsried  Munich  82152  Germany
Phone: 49-0-89-899-27-0 Fax: 49-0-89-899-27-222


SEARCH JOBS


Industry
Biotechnology






Company News
MorphoSys AG Reports Publication Of Clinical Case Report Of A Blood Cancer (DLBCL) Patient Showing Long-Lasting Complete Remission Of Currently 26 Months Under MOR208 Treatment 6/17/2016 9:27:24 AM
ASCO2016: MorphoSys AG Presents Updated Clinical Data For MOR202 In Multiple Myeloma And For MOR208 In Non-Hodgkin's Lymphoma At ASCO 2016 6/6/2016 3:18:48 PM
MorphoSys AG Reports Outcome Of Annual General Meeting 2016 6/2/2016 9:53:26 AM
MorphoSys AG To Present Clinical Trial Data On Proprietary Programs At Upcoming ASCO Annual Meeting 2016 5/19/2016 9:59:12 AM
MorphoSys AG To Present At Three Upcoming Conferences 5/4/2016 9:45:39 AM
MorphoSys AG Reports Results For The First Three Months Of 2016 5/3/2016 8:32:52 AM
MorphoSys AG To Host Q1 2016 Conference Call On May 3, 2016 4/27/2016 9:19:29 AM
MorphoSys AG Licensing Partner GlaxoSmithKline (GSK) Starts Phase 2 Study With GSK3196165 (MOR103) In Hand Osteoarthritis 4/18/2016 9:43:31 AM
Galapagos (GLPG.BR) And MorphoSys AG Initiate Phase I Study In Joint Antibody Program MOR106 4/7/2016 10:38:37 AM
MorphoSys AG Initiates Phase 2 Combination Trial Of MOR208 And Lenalidomide In Patients With Relapsed Or Refractory Diffuse Large B Cell Lymphoma (DLBCL) 4/6/2016 10:26:52 AM
12345678910...
//-->